Found: 28
Select item for more details and to access through your institution.
Autologous stem cell transplantation for non-Hodgkin’s lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens.
- Published in:
- Bone Marrow Transplantation, 2001, v. 28, n. 5, p. 455, doi. 10.1038/sj.bmt.1703179
- By:
- Publication type:
- Article
High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancer.
- Published in:
- Bone Marrow Transplantation, 2000, v. 26, n. 1, p. 51, doi. 10.1038/sj.bmt.1702461
- By:
- Publication type:
- Article
Transplantation of CD34<sup>+</sup> peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial.
- Published in:
- Bone Marrow Transplantation, 2000, v. 25, n. 11, p. 1165, doi. 10.1038/sj.bmt.1702415
- By:
- Publication type:
- Article
A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients.
- Published in:
- Bone Marrow Transplantation, 2000, v. 25, n. 3, p. 283
- By:
- Publication type:
- Article
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer.
- Published in:
- Bone Marrow Transplantation, 1998, v. 22, n. 7, p. 651, doi. 10.1038/sj.bmt.1701398
- By:
- Publication type:
- Article
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer.
- Published in:
- Bone Marrow Transplantation, 1997, v. 19, n. 12, p. 1183, doi. 10.1038/sj.bmt.1700820
- By:
- Publication type:
- Article
Reversal of infection with Mycobacterium avium intracellulare by treatment with alpha-interferon in a patient with hairy cell leukemia.
- Published in:
- 1988
- By:
- Publication type:
- journal article
Chronic GvHD-associated serositis and pericarditis.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 8, p. 1098, doi. 10.1038/bmt.2015.105
- By:
- Publication type:
- Article
Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 11, p. 1360, doi. 10.1038/bmt.2014.161
- By:
- Publication type:
- Article
Effects of spleen status on early outcomes after hematopoietic cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 6, p. 825, doi. 10.1038/bmt.2012.249
- By:
- Publication type:
- Article
Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: results from the expanded access program.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 6, p. 777, doi. 10.1038/bmt.2012.219
- By:
- Publication type:
- Article
Clinical experience with a simple algorithm for plerixafor utilization in autologous stem cell mobilization.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 12, p. 1526, doi. 10.1038/bmt.2012.74
- By:
- Publication type:
- Article
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 810, doi. 10.1038/bmt.2011.194
- By:
- Publication type:
- Article
Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia.
- Published in:
- Bone Marrow Transplantation, 2010, v. 45, n. 10, p. 1479, doi. 10.1038/bmt.2010.134
- By:
- Publication type:
- Article
Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization.
- Published in:
- Bone Marrow Transplantation, 2010, v. 45, n. 1, p. 39, doi. 10.1038/bmt.2009.119
- By:
- Publication type:
- Article
Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience.
- Published in:
- Bone Marrow Transplantation, 2009, v. 43, n. 12, p. 909, doi. 10.1038/bmt.2008.409
- By:
- Publication type:
- Article
Isolation in the allogeneic transplant environment: how protective is it?
- Published in:
- Bone Marrow Transplantation, 2005, v. 36, n. 5, p. 373, doi. 10.1038/sj.bmt.1705040
- By:
- Publication type:
- Article
Autologous stem cell transplantation for Hodgkin's disease: busulfan, melphalan and thiotepa compared to a radiation-based regimen.
- Published in:
- Bone Marrow Transplantation, 2003, v. 32, n. 3, p. 279, doi. 10.1038/sj.bmt.1704110
- By:
- Publication type:
- Article
Toxic megacolon: a life-threatening complication of high-dose therapy and autologous stem cell transplantation among patients with AL amyloidosis.
- Published in:
- Bone Marrow Transplantation, 2002, v. 30, n. 5, p. 279, doi. 10.1038/sj.bmt.1703627
- By:
- Publication type:
- Article
High-throughput mutational screen of the tyrosine kinome in chronic myelomonocytic leukemia.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.
- Published in:
- Leukemia (08876924), 2003, v. 17, n. 3, p. 481, doi. 10.1038/sj.leu.2402848
- By:
- Publication type:
- Article
BISPECIFIC ANTI‐CD20/19 CAR‐T—ZAMTOCABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY DLBCL—INTERIM ANALYSIS RESULTS OF DALY‐II‐USA STUDY.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 147, doi. 10.1002/hon.3163_96
- By:
- Publication type:
- Article
'Don't keep me waiting': estimating the impact on lifetime survival and QALYs of reduced vein‐to‐vein time for LBCL patients treated with CAR T in the 3L+ setting.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 541, doi. 10.1002/hon.3164_401
- By:
- Publication type:
- Article
COMPARATIVE EFFICACY OF TISAGENLECLEUCEL (TISA‐CEL) AND LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL)
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.184_2880
- By:
- Publication type:
- Article
INTRAVENOUS IMMUNOGLOBULIN THERAPY USE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL IN THE JULIET TRIAL.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 505, doi. 10.1002/hon.189_2631
- By:
- Publication type:
- Article
CORRELATIVE ANALYSES OF CYTOKINE RELEASE SYNDROME AND NEUROLOGICAL EVENTS IN TISAGENLECLEUCEL‐TREATED RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 308, doi. 10.1002/hon.118_2630
- By:
- Publication type:
- Article
INTRAVENOUS IMMUNOGLOBULIN THERAPY USE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL IN THE JULIET TRIAL.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 505, doi. 10.1002/hon.189_2631
- By:
- Publication type:
- Article
CORRELATIVE ANALYSES OF CYTOKINE RELEASE SYNDROME AND NEUROLOGICAL EVENTS IN TISAGENLECLEUCEL‐TREATED RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 308, doi. 10.1002/hon.118_2630
- By:
- Publication type:
- Article